Altered phenotypic and functional characteristics of CD3+CD56+ NKT-like cells in human gastric cancer.

Liu-Sheng Peng,Fang-Yuan Mao,Yong-Liang Zhao,Ting-Ting Wang,Na Chen,Jin-Yu Zhang,Ping Cheng,Wen-Hua Li,Yi-Pin Lv,Yong-Sheng Teng,Gang Guo,Ping Luo,Weisan Chen,Quan-Ming Zou,Yuan Zhuang

DOI: https://doi.org/10.18632/oncotarget.10484

2016-01-01

Oncotarget

Abstract:CD3(+)CD56(+) natural killer T (NKT)-like cells are a group of CD3(+) T cells sharing characteristics of NK and T cells and constitute a major component of host antitumor immune response in human cancer. However, the nature, function and clinical relevance of CD3(+)CD56(+) NKT-like cells in human gastric cancer (GC) remain unclear. In this study, we showed that the frequencies of CD3(+)CD56(+) NKT-like cells in GC tumors were significantly decreased and low levels of tumor-infiltrating CD3(+)CD56(+) NKT-like cells were positively correlated with poor survival and disease progression. Most CD3(+)CD56(+) NKT-like cells in GC tumors were CD45RA(-)CD27(+/-)central/effector-memory cells with decreased activity and lower expression levels of CD69, NKG2D and DNAM-1 than those in non-tumor tissues. We further observed that tumor-infiltrating CD3(+)CD56(+) NKT-like cells had impaired effector function as shown by decreased IFN-gamma, TNF-a, granzyme B and Ki-67 expression. Moreover, in vitro studies showed that soluble factors released from GC tumors could induce the functional impairment of CD3(+)CD56(+) NKT-like cells. Collectively, our data indicate that decreased tumor-infiltrating CD3(+)CD56(+) NKT-like cells with impaired effector function are associated with tumor progression and poor survival of GC patients, which may contribute to immune escape of GC.